Дата випуску | Назва | Автор(и) |
2021 | A potential role of fecal oxalate-degrading activity in oxalate homeostasis in end-stage renal disease patients; a descriptive pilot study | Stepanova, N.; Tolstanova, G.; Korol, L.; Akulenko, I.; Savchenko, O.; Kolesnyk, M. |
2018 | Antioxidant effects of immunomodulators in patients with recurrent pyelonephritis | Kolesnyk, M.; Korol, L.; Stepanova, N.; Driianska, V.; Migal, L.; Savchenko, V. |
2022 | Armed conflicts and kidney patients: a consensus statement from the Renal Disaster Relief Task Force of the ERA | Sever, M.; Vanholder, R.; Luyckx, V.; Eckardt, K.; Kolesnyk, M.; Wiecek, A.; Pawlowicz-Szlarska, E.; Gallego, D.; Shroff, R.; Škoberne, A.; Nistor, I.; Sekkarie, M.; Ivanov, D.; Noruišiene, E.; Tuglular, S. |
2019-03 | Can hyperoxaluria cause kidney damage in women with recurrent pyelonephritis? | Stepanova, N.; Kolesnyk, M.; Driianska, V.; Korol, L. |
2019 | Extracellular overhydration in peritoneal dialysis patients linked with increased oxidative stress | Stepanova, N.; Korol, L.; Burdeyna, O.; Kolesnyk, M. |
2020 | History of studying the kidney pathology in the mirror of numismatics. Report 1. Antiquity and middle ages | Syniachenko, O.; Kolesnyk, M.; Stepanova, N.; Iermolaieva, M. |
2022 | Lifesaving Care for Patients with Kidney Failure during the War in Ukraine | Stepanova, N.; Kolesnyk, M.; Mithani, Z.; Alkofair, B.; Shakour, R.; Petrova, A.; Novakivskyy, V.; Hymes, J.; Brzosko, S.; Giullian, J.; Espinel, Z.; Shultz, J. |
2022-07 | Lifesaving Care for Patients with Kidney Failure during the War in Ukraine 2022 | Stepanova, N.; Kolesnyk, M.; Mithani, Z.; Alkofair, B.; Shakour, B.; Petrova, A.; Novakivskyy, V.; Hymes, J.; Brzosko, S.; Giullian, J.; Espinel, Z.; Shultz, J. |
2020 | Oxalate-degrading activity in fecal microbiota associated with blood lipid profile in dialysis patients | Stepanova, N.; Tolstanova, G.; Akulenko, I.; Savchenko, O.; Lebid, L.; Skovorodka, M.; Kolesnyk, M. |
2020 | Prevention, diagnosis and management of influenza in CKD patients: Adapted clinical guidelines of the Ukrainian Association of Nephrologists and Kidney Transplant Specialists | Kolesnyk, M.; Stepanova, N.; Snisar, L.; Liksunova, L.; Lebid, L.; Velychko, M. |
2020 | Regulation of oxalate homeostasis by oxalate-degrading activity in fecal microbiota in dialysis patients | Stepanova, N.; Tolstanova, G.; Akulenko, I.; Korol, L.; Savchenko, O.; Snisar, L.; Kolesnyk, M. |
2021 | The long-term effects of acute kidney injury on intestinal oxalate-degrading bacteria in rats. Nephrol Dial Transplant | Stepanova, N.; Tolstanova, G.; Nepomnyashchii, V.; Akulenko, I.; Savchenko, S.; Kolesnyk, M. |
2019-05 | The predictive value of hyperuricemia in residual diuresis decline in peritoneal dialysis patients | Stepanova, N.; Surzhko, L.; Lebid, L.; Snisar, L.; Kolesnyk, M. |
2020 | The predictive value of serum uric acid in primary glomerulonephritis patients: a 5-years renal prognosis | Kolesnyk, M.; Stepanova, N.; Snisar, L.; Lebid, L. |
2018 | The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patients | Stepanova, N.; Korol, L.; Novakivskyy, V.; Kolesnyk, M. |
2019-10 | Urinary and peritoneal uric acid excretion is associated with peritoneal dialysis technique failure | Stepanova, N.; Kolesnyk, M.; Snisar, L.; Lebid, L.; Kutsenko, M. |